IMAP Germany advises Felss Group on the sale of a majority stake to Capvis

Client Background & Objective

​Founded in 1905, Felss Group today employs approximately 600 employees at six production sites in Europe, Asia and USA. Annual revenues amount to around € 125m, having nearly tripled in the past decade. Felss Group serves numerous international blue-chip automotive suppliers and OEMs, including Bosch, GKN, IFA Rotorion, VW and Mercedes Benz. Its product range comprises highly-engineered cold forming machine tools, as well as customized light-weight precision components.

IMAP Advantage & Approach

​Following a competitive beauty contest IMAP was mandated by the owner to exclusively advise on the transaction. Vital elements for the mutual success of the transaction:

• a well-structured preparation and documentation of the company

• a careful selection of suitable potential investors

• a close alignment with the owner, the management team as well as the legal and transaction service advisors

• a competitive process without exclusivity until signing

The duration between investor`s approach and signing was only 3.5 months.

Outcome & Impact

With Capvis, IMAP successfully found an investor who is very experienced in managing corporate successions. Capvis will support the Felss group with equity as well as with management experience in international expansion and tapping into new customer groups.

Capvis is a leading private equity company based in Switzerland. As one of the most active investors in German speaking Europe, Capvis invests from its € 720m fund mainly in majority stakes of leading, mid-sized companies. Since 1950 Capvis has managed about 50 transactions worth more than 50 bn Euros.


Vendor Mrs. Kienhöfer stated: “It was pivotal to find an investor who shares our philosophy and values, and who understands the synergies stemming from an integrated machine tool and component manufacturing.” Mrs. Kienhöfer will remain minority shareholder in the Group as well as member of the advisory council.


Dr. Carsten Lehmann

+49 621 328623

More news